Streeter P R, Fortner G W
Division of Biology, Kansas State University, Manhattan 66506.
Transplantation. 1988 Aug;46(2):256-60. doi: 10.1097/00007890-198808000-00014.
Previously, we hypothesized that natural killer lymphocytes could function as effector cells in the rejection of UV-induced tumors in tumor-immune animals. Immunization with progressor UV-tumor 2237 induced lymphocytes exhibiting natural cell-mediated cytotoxicity but failed to elicit tumor-specific cytolytic T lymphocytes. In the present investigation, T lymphocyte cloning technology provided a means of isolating homogeneous lymphocyte populations exhibiting CTL and NK activities. Clones with both CTL and NK activity were isolated from regressor-1316-immune mice, but NK-like clones only were isolated from progressor-2237-immune mice. An evaluation of the in situ anti-UV-tumor action of a representative NK lymphocyte clone revealed that these cells could in fact prevent tumor outgrowth, supporting our hypothesis that these cells could function as effector cells in UV-tumor rejection responses in tumor-immune animals.
先前,我们曾假设自然杀伤淋巴细胞在肿瘤免疫动物中可作为效应细胞参与紫外线诱导肿瘤的排斥反应。用进展期紫外线肿瘤2237进行免疫诱导出了具有天然细胞介导细胞毒性的淋巴细胞,但未能引发肿瘤特异性细胞溶解T淋巴细胞。在本研究中,T淋巴细胞克隆技术提供了一种分离表现出CTL和NK活性的同质淋巴细胞群体的方法。从消退期1316免疫小鼠中分离出了同时具有CTL和NK活性的克隆,但从进展期2237免疫小鼠中仅分离出了NK样克隆。对一个代表性NK淋巴细胞克隆的原位抗紫外线肿瘤作用的评估表明,这些细胞实际上可以阻止肿瘤生长,支持了我们的假设,即这些细胞在肿瘤免疫动物的紫外线肿瘤排斥反应中可作为效应细胞发挥作用。